Show simple item record

dc.contributor.authorZhu, Qingfu
dc.contributor.authorHeon, Mikala
dc.contributor.authorZhao, Zheng
dc.contributor.authorHe, Mei
dc.date.accessioned2018-05-15T16:18:19Z
dc.date.available2018-05-15T16:18:19Z
dc.date.issued2018-05-04
dc.identifier.citationQ. Zhu, M. E. Heon, Z. Zhao and M. He, Lab Chip, 2018, DOI: 10.1039/C8LC00246K.en_US
dc.identifier.urihttp://hdl.handle.net/1808/26426
dc.description.abstractStudying extracellular vesicle (EV), particularly exosomes, is holding great promise, yet technically challenging in defining such small and molecularly diverse nanovesicles. With intrinsic molecular payload and biodegradability, molecular engineering of exosomes opens new avenues for mediating cellular responses and developing novel nano-delivery systems in precision therapeutics. Microfluidic lab-on-chip technology is taking pivotal roles in such emerging field. This review examines scientific advancements of microfluidic technology for engineering exosomes and assesses future applications and perspectives in developing precision therapeutics, which could serve the community by identifying potential new research areas or technologies that are urgently needed in precision therapeutics.en_US
dc.publisherRoyal Society of Chemistryen_US
dc.titleMicrofluidic Engineering of Exosomes: Editing Cellular Messages for Precision Therapeuticsen_US
dc.typeArticleen_US
kusw.kuauthorZhu, Qingfu
kusw.kuauthorHeon, Mikala
kusw.kuauthorZhao, Zheng
kusw.kuauthorHe, Mei
kusw.kudepartmentChemical and Petroleum Engineeringen_US
dc.identifier.doi10.1039/C8LC00246Ken_US
dc.identifier.orcidhttps://orcid.org/0000-0001-7068-1321
kusw.oaversionScholarly/refereed, author accepted manuscripten_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record